Asianet Newsable on MSN
RZLT stock lost nearly 90% of its value today – what did the company’s latest trial reveal?
Rezolute said that its Phase 3 sunRIZE trial of ersodetug to treat low blood pressure failed to meet its primary endpoint.
The 2025 winter graduating class is comprised of 36 undergraduates and eight graduate degree recipients.The procession will ...
The latest ThreatsDay Bulletin breaks down the week’s biggest stories — rootkits evading Windows, Docker leaks, AI risks and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback